Renaissance Technologies (RenTech)'s RMD Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 304,480 shares of ResMed Inc. (RMD) worth $73.34 M, representing 0.11% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 47 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in RMD, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2015, adding 1.36 M shares. Largest reduction occurred in Q4 2016, reducing 1.04 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s ResMed (RMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ResMed (RMD) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +246,480 | Add 424.97% | 304,480 | $240.87 |
| Q3 2025 | -45,000 | Reduce 43.69% | 58,000 | $273.73 |
| Q2 2025 | +49,000 | Add 90.74% | 103,000 | $258.00 |
| Q1 2025 | -193,700 | Reduce 78.20% | 54,000 | $223.85 |
| Q4 2024 | +163,700 | Add 194.88% | 247,700 | $228.69 |
| Q3 2024 | -135,600 | Reduce 61.75% | 84,000 | $244.12 |
| Q2 2024 | +219,600 | New Buy | 219,600 | $191.42 |
| Q4 2023 | -405,200 | Sold Out | 0 | $0.00 |
| Q3 2023 | +14,500 | Add 3.71% | 405,200 | $147.87 |
| Q2 2023 | +261,500 | Add 202.40% | 390,700 | $0.22 |
| Q1 2023 | -95,696 | Reduce 42.55% | 129,200 | $0.22 |
| Q4 2022 | +178,340 | Add 383.07% | 224,896 | $0.21 |
| Q3 2022 | +3,908 | Add 9.16% | 46,556 | $217.93 |
| Q2 2022 | +21,913 | Add 105.68% | 42,648 | $210.02 |
| Q1 2022 | -16,503 | Reduce 44.32% | 20,735 | $242.78 |
| Q4 2021 | +35,266 | Add 1788.34% | 37,238 | $260.19 |
| Q3 2021 | +1,972 | New Buy | 1,972 | $269.27 |
| Q2 2021 | -6,887 | Sold Out | 0 | $0.00 |
| Q1 2021 | +3,680 | Add 114.75% | 6,887 | $191.96 |
| Q4 2020 | -9,893 | Reduce 75.52% | 3,207 | $209.54 |
| Q3 2020 | +13,100 | New Buy | 13,100 | $171.45 |
| Q1 2020 | -128,546 | Sold Out | 0 | $0.00 |
| Q4 2019 | +121,446 | Add 1710.51% | 128,546 | $154.91 |
| Q3 2019 | -22,269 | Reduce 75.82% | 7,100 | $135.07 |
| Q2 2019 | +29,369 | New Buy | 29,369 | $120.50 |
| Q1 2019 | -333,424 | Sold Out | 0 | $0.00 |
| Q4 2018 | -414,476 | Reduce 55.42% | 333,424 | $113.54 |
| Q3 2018 | +447,649 | Add 149.09% | 747,900 | $115.34 |
| Q2 2018 | +118,928 | Add 65.59% | 300,251 | $103.72 |
| Q1 2018 | -100,911 | Reduce 35.75% | 181,323 | $97.48 |
| Q4 2017 | +235,734 | Add 506.95% | 282,234 | $84.96 |
| Q3 2017 | +46,500 | New Buy | 46,500 | $76.97 |
| Q2 2017 | -32,700 | Sold Out | 0 | $0.00 |
| Q1 2017 | -352,600 | Reduce 91.51% | 32,700 | $71.96 |
| Q4 2016 | -1.04 M | Reduce 72.90% | 385,300 | $62.05 |
| Q3 2016 | +632,900 | Add 80.25% | 1.42 M | $64.79 |
| Q2 2016 | -494,400 | Reduce 38.53% | 788,700 | $63.23 |
| Q1 2016 | +17,000 | Add 1.34% | 1.28 M | $57.82 |
| Q4 2015 | -94,900 | Reduce 6.97% | 1.27 M | $53.69 |
| Q3 2015 | +1.36 M | New Buy | 1.36 M | $50.96 |
| Q2 2015 | -83,100 | Sold Out | 0 | $0.00 |
| Q1 2015 | -369,800 | Reduce 81.65% | 83,100 | $71.78 |
| Q4 2014 | +452,900 | New Buy | 452,900 | $56.06 |
| Q2 2014 | -14,800 | Sold Out | 0 | $0.00 |
| Q1 2014 | -605,000 | Reduce 97.61% | 14,800 | $44.66 |
| Q4 2013 | -72,300 | Reduce 10.45% | 619,800 | $47.08 |
| Q3 2013 | +692,100 | New Buy | 692,100 | $52.82 |
Renaissance Technologies (RenTech)'s ResMed Investment FAQs
Renaissance Technologies (RenTech) first purchased ResMed Inc. (RMD) in Q3 2013, acquiring 692,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held ResMed Inc. (RMD) for 47 quarters since Q3 2013.
Renaissance Technologies (RenTech)'s largest addition to ResMed Inc. (RMD) was in Q3 2015, adding 1,361,000 shares worth $69.36 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 304,480 shares of ResMed Inc. (RMD), valued at approximately $73.34 M.
As of the Q4 2025 filing, ResMed Inc. (RMD) represents approximately 0.11% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in ResMed Inc. (RMD) was 1,421,600 shares, as reported at the end of Q3 2016.